The application discloses a
cucurbitacin B derivative A2, a preparation method and application thereof, and the
structural formula of the
cucurbitacin B derivative A2 is provided. 50 The
cucurbitacin B derivative A2 provided by the application has a strong
inhibitory effect on the
proliferation activity of a human non-
small cell lung cancer cell line A549, and the IC value is only 0.009 muM, which is increased by nearly 10 times than the inhibitory activity of
cucurbitacin B on the proliferation of A549, and the
toxicity to normal cells L02 is reduced by nearly 10 times, and the selectivity coefficient is increased by nearly 100 times than cucurbitacin. The xenograft mouse experiment result is consistent with the
cell result, and can be used as a candidate
drug for treating human non-
small cell lung cancer; the preparation method has the advantages of rich
raw material source, mild reaction condition, convenient operation in reaction process, cheap and easily obtained
reagent,
low toxicity or non-
toxicity, low cost and suitability for industrial production.